StrandSmartTM    is a San Francisco based new-age diagnostics company with a data-driven approach to stage-shifting cancer

Our team is developing blood tests to provide primary care physicians with a first alert for otherwise seemingly healthy patients

Most cancers are detected at later stages, when survival rates are lower and treatments are more costly and potentially harmful

We envision a world where cancers are caught early enough to be curable or better managed

Effective screening options currently only exist for 4 out of 100s of cancer types

Cancer is a data problem, and the solution is data driven

If you have inquiries related to clinical trials, employment opportunities, investment opportunities, or other inquiries:

Click here

OUR FOUNDING TEAM

Adrianna Davies
Chief Executive Officer

Mark D. Myslinski
Chief Product Officer

Don Howard, MD, PhD
Chief Medical Officer

Wesley D. Blakeslee
General Counsel

Diana Maichin
Chief Operating Officer

If you have inquiries related to clinical trials, employment opportunities, investment opportunities, or other inquiries:

Click here

Copyright © 2019 StrandSmartTM, Inc. All Rights Reserved.

Data driven

New-age diagnostics

Stage-shifting cancer

Email: stageshift@strandsmart.com               Inquiries: (415) 741-4836 

Dr. Balaji Panchapakesan PhD
Chief Scientific Advisor

TM